Voriconazole topical cream formulation: evidence for stability and antifungal activity

Autor: Philippe-Henri Secrétan, Romain Guery, David Nguyen, Salvatore Cisternino, Fanny Lanternier, Fabrice Vidal, Sylvain Auvity, Olivier Lortholary, Joël Schlatter, Camille Bouchand, Jérémie F. Cohen

Publikováno v: International Journal of Antimicrobial Agents
International Journal of Antimicrobial Agents, 2020, 56 (3), pp.106083. ⟨10.1016/j.ijantimicag.2020.106083⟩
International Journal of Antimicrobial Agents, 2020, 56, pp.106083-. ⟨10.1016/j.ijantimicag.2020.106083⟩

International audience; Systemic use of voriconazole (VCZ) might be restricted by adverse events, such as hepatotoxicity and neurotoxicity, or drug-drug interactions. Topical VCZ application to skin may help to treat local infection more effectively

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a158597fbfed0e773db66906205ca0bf
https://pubmed.ncbi.nlm.nih.gov/32659465